(Total Views: 373)
Posted On: 05/01/2024 10:38:48 AM
Post# of 22461
It doesn't look good for the home team.
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product April 18, 2024
https://ca.finance.yahoo.com/news/revive-ther...00050.html
No mention of QMC or quantum dots involved
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product April 18, 2024
Quote:
The Company entered into a license agreement with Lawson Health Research Institute (You remember these guys they gave QMC an exclusive in Nov 2022) for the worldwide exclusive rights to the intellectual property of novel blood biomarkers that characterize long COVID.
https://ca.finance.yahoo.com/news/revive-ther...00050.html
No mention of QMC or quantum dots involved
(0)
(0)Scroll down for more posts ▼
